nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—CYP3A4—Everolimus—kidney cancer	0.117	0.293	CbGbCtD
Lurasidone—CYP3A4—Temsirolimus—kidney cancer	0.079	0.198	CbGbCtD
Lurasidone—CYP3A4—Pazopanib—kidney cancer	0.0415	0.104	CbGbCtD
Lurasidone—CYP3A4—Erlotinib—kidney cancer	0.0296	0.0741	CbGbCtD
Lurasidone—CYP3A4—Paclitaxel—kidney cancer	0.0271	0.0678	CbGbCtD
Lurasidone—CYP3A4—Sorafenib—kidney cancer	0.0241	0.0603	CbGbCtD
Lurasidone—CYP3A4—Vinblastine—kidney cancer	0.0238	0.0595	CbGbCtD
Lurasidone—CYP3A4—Vincristine—kidney cancer	0.0234	0.0585	CbGbCtD
Lurasidone—CYP3A4—Sunitinib—kidney cancer	0.0195	0.0488	CbGbCtD
Lurasidone—CYP3A4—Doxorubicin—kidney cancer	0.0146	0.0366	CbGbCtD
Lurasidone—HTR2A—urine—kidney cancer	0.0013	0.14	CbGeAlD
Lurasidone—CYP3A4—urine—kidney cancer	0.00121	0.129	CbGeAlD
Lurasidone—HTR1A—renal system—kidney cancer	0.000535	0.0573	CbGeAlD
Lurasidone—ADRA2C—nephron tubule—kidney cancer	0.000517	0.0554	CbGeAlD
Lurasidone—HTR7—renal system—kidney cancer	0.000511	0.0548	CbGeAlD
Lurasidone—HTR7—kidney—kidney cancer	0.000494	0.053	CbGeAlD
Lurasidone—ADRA2C—renal system—kidney cancer	0.00047	0.0504	CbGeAlD
Lurasidone—HTR7—gonad—kidney cancer	0.000458	0.0491	CbGeAlD
Lurasidone—ADRA2C—kidney—kidney cancer	0.000454	0.0487	CbGeAlD
Lurasidone—Hyperhidrosis—Vincristine—kidney cancer	0.00045	0.000762	CcSEcCtD
Lurasidone—Hepatobiliary disease—Capecitabine—kidney cancer	0.00045	0.000761	CcSEcCtD
Lurasidone—Pruritus—Erlotinib—kidney cancer	0.00045	0.000761	CcSEcCtD
Lurasidone—Fatigue—Dactinomycin—kidney cancer	0.00045	0.00076	CcSEcCtD
Lurasidone—Flatulence—Paclitaxel—kidney cancer	0.000447	0.000756	CcSEcCtD
Lurasidone—Agranulocytosis—Capecitabine—kidney cancer	0.000444	0.000751	CcSEcCtD
Lurasidone—ADRA2C—cortex of kidney—kidney cancer	0.000442	0.0474	CbGeAlD
Lurasidone—Infection—Gemcitabine—kidney cancer	0.000439	0.000743	CcSEcCtD
Lurasidone—Back pain—Paclitaxel—kidney cancer	0.000439	0.000742	CcSEcCtD
Lurasidone—Dizziness—Vinblastine—kidney cancer	0.000438	0.00074	CcSEcCtD
Lurasidone—Dizziness—Everolimus—kidney cancer	0.000436	0.000737	CcSEcCtD
Lurasidone—Muscle spasms—Paclitaxel—kidney cancer	0.000436	0.000737	CcSEcCtD
Lurasidone—Abdominal pain—Sunitinib—kidney cancer	0.000435	0.000736	CcSEcCtD
Lurasidone—Diarrhoea—Erlotinib—kidney cancer	0.000435	0.000736	CcSEcCtD
Lurasidone—Hypotension—Vincristine—kidney cancer	0.000435	0.000736	CcSEcCtD
Lurasidone—Bradycardia—Capecitabine—kidney cancer	0.000435	0.000736	CcSEcCtD
Lurasidone—Nervous system disorder—Gemcitabine—kidney cancer	0.000433	0.000733	CcSEcCtD
Lurasidone—Skin disorder—Gemcitabine—kidney cancer	0.000429	0.000726	CcSEcCtD
Lurasidone—Vision blurred—Paclitaxel—kidney cancer	0.000427	0.000723	CcSEcCtD
Lurasidone—Hyperhidrosis—Gemcitabine—kidney cancer	0.000427	0.000723	CcSEcCtD
Lurasidone—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000426	0.000721	CcSEcCtD
Lurasidone—Hot flush—Doxorubicin—kidney cancer	0.000426	0.00072	CcSEcCtD
Lurasidone—Tremor—Paclitaxel—kidney cancer	0.000425	0.000718	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000424	0.000718	CcSEcCtD
Lurasidone—Increased appetite—Doxorubicin—kidney cancer	0.000424	0.000717	CcSEcCtD
Lurasidone—Urinary tract disorder—Capecitabine—kidney cancer	0.000422	0.000714	CcSEcCtD
Lurasidone—Menopausal symptoms—Doxorubicin—kidney cancer	0.000422	0.000714	CcSEcCtD
Lurasidone—Insomnia—Vincristine—kidney cancer	0.000421	0.000713	CcSEcCtD
Lurasidone—Vomiting—Vinblastine—kidney cancer	0.000421	0.000712	CcSEcCtD
Lurasidone—ADRA2C—cardiac atrium—kidney cancer	0.000421	0.0451	CbGeAlD
Lurasidone—Dizziness—Erlotinib—kidney cancer	0.000421	0.000712	CcSEcCtD
Lurasidone—Connective tissue disorder—Capecitabine—kidney cancer	0.00042	0.00071	CcSEcCtD
Lurasidone—Vomiting—Everolimus—kidney cancer	0.000419	0.000709	CcSEcCtD
Lurasidone—Anaemia—Paclitaxel—kidney cancer	0.000419	0.000709	CcSEcCtD
Lurasidone—Urethral disorder—Capecitabine—kidney cancer	0.000419	0.000709	CcSEcCtD
Lurasidone—Agitation—Paclitaxel—kidney cancer	0.000417	0.000705	CcSEcCtD
Lurasidone—Rash—Everolimus—kidney cancer	0.000416	0.000703	CcSEcCtD
Lurasidone—Dermatitis—Everolimus—kidney cancer	0.000415	0.000702	CcSEcCtD
Lurasidone—Angioedema—Paclitaxel—kidney cancer	0.000414	0.000701	CcSEcCtD
Lurasidone—Hypotension—Gemcitabine—kidney cancer	0.000413	0.000698	CcSEcCtD
Lurasidone—Abdominal pain—Dactinomycin—kidney cancer	0.000412	0.000697	CcSEcCtD
Lurasidone—Asthenia—Sorafenib—kidney cancer	0.000411	0.000695	CcSEcCtD
Lurasidone—Malaise—Paclitaxel—kidney cancer	0.000409	0.000691	CcSEcCtD
Lurasidone—Vertigo—Paclitaxel—kidney cancer	0.000407	0.000689	CcSEcCtD
Lurasidone—Syncope—Paclitaxel—kidney cancer	0.000407	0.000688	CcSEcCtD
Lurasidone—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000406	0.000687	CcSEcCtD
Lurasidone—Lethargy—Doxorubicin—kidney cancer	0.000406	0.000687	CcSEcCtD
Lurasidone—Leukopenia—Paclitaxel—kidney cancer	0.000406	0.000686	CcSEcCtD
Lurasidone—Decreased appetite—Vincristine—kidney cancer	0.000405	0.000685	CcSEcCtD
Lurasidone—Pruritus—Sorafenib—kidney cancer	0.000405	0.000685	CcSEcCtD
Lurasidone—Vomiting—Erlotinib—kidney cancer	0.000405	0.000684	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000403	0.000681	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Vincristine—kidney cancer	0.000402	0.00068	CcSEcCtD
Lurasidone—Fatigue—Vincristine—kidney cancer	0.000402	0.000679	CcSEcCtD
Lurasidone—Rash—Erlotinib—kidney cancer	0.000401	0.000678	CcSEcCtD
Lurasidone—Dermatitis—Erlotinib—kidney cancer	0.000401	0.000678	CcSEcCtD
Lurasidone—Insomnia—Gemcitabine—kidney cancer	0.0004	0.000676	CcSEcCtD
Lurasidone—Eye disorder—Capecitabine—kidney cancer	0.000399	0.000675	CcSEcCtD
Lurasidone—Loss of consciousness—Paclitaxel—kidney cancer	0.000398	0.000674	CcSEcCtD
Lurasidone—Osteoarthritis—Doxorubicin—kidney cancer	0.000398	0.000673	CcSEcCtD
Lurasidone—Cardiac disorder—Capecitabine—kidney cancer	0.000397	0.000671	CcSEcCtD
Lurasidone—Asthenia—Sunitinib—kidney cancer	0.000395	0.000668	CcSEcCtD
Lurasidone—Dyspnoea—Gemcitabine—kidney cancer	0.000394	0.000666	CcSEcCtD
Lurasidone—Nausea—Vinblastine—kidney cancer	0.000393	0.000665	CcSEcCtD
Lurasidone—Somnolence—Gemcitabine—kidney cancer	0.000393	0.000664	CcSEcCtD
Lurasidone—Convulsion—Paclitaxel—kidney cancer	0.000393	0.000664	CcSEcCtD
Lurasidone—Nausea—Everolimus—kidney cancer	0.000392	0.000662	CcSEcCtD
Lurasidone—Diarrhoea—Sorafenib—kidney cancer	0.000392	0.000662	CcSEcCtD
Lurasidone—Hypertension—Paclitaxel—kidney cancer	0.000391	0.000662	CcSEcCtD
Lurasidone—Pruritus—Sunitinib—kidney cancer	0.00039	0.000659	CcSEcCtD
Lurasidone—Angiopathy—Capecitabine—kidney cancer	0.000388	0.000656	CcSEcCtD
Lurasidone—Myalgia—Paclitaxel—kidney cancer	0.000386	0.000653	CcSEcCtD
Lurasidone—Anxiety—Paclitaxel—kidney cancer	0.000385	0.00065	CcSEcCtD
Lurasidone—Decreased appetite—Gemcitabine—kidney cancer	0.000384	0.00065	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000383	0.000648	CcSEcCtD
Lurasidone—Arrhythmia—Capecitabine—kidney cancer	0.000382	0.000646	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000382	0.000645	CcSEcCtD
Lurasidone—Fatigue—Gemcitabine—kidney cancer	0.000381	0.000644	CcSEcCtD
Lurasidone—Gastrointestinal pain—Vincristine—kidney cancer	0.000381	0.000644	CcSEcCtD
Lurasidone—Dizziness—Sorafenib—kidney cancer	0.000379	0.00064	CcSEcCtD
Lurasidone—Nausea—Erlotinib—kidney cancer	0.000378	0.000639	CcSEcCtD
Lurasidone—Dry mouth—Paclitaxel—kidney cancer	0.000377	0.000638	CcSEcCtD
Lurasidone—Diarrhoea—Sunitinib—kidney cancer	0.000377	0.000637	CcSEcCtD
Lurasidone—Mental disorder—Capecitabine—kidney cancer	0.000374	0.000633	CcSEcCtD
Lurasidone—Asthenia—Dactinomycin—kidney cancer	0.000374	0.000633	CcSEcCtD
Lurasidone—Blood creatinine increased—Doxorubicin—kidney cancer	0.000373	0.000631	CcSEcCtD
Lurasidone—Malnutrition—Capecitabine—kidney cancer	0.000372	0.000629	CcSEcCtD
Lurasidone—Abdominal pain—Vincristine—kidney cancer	0.000368	0.000623	CcSEcCtD
Lurasidone—Infection—Paclitaxel—kidney cancer	0.000368	0.000622	CcSEcCtD
Lurasidone—Flatulence—Capecitabine—kidney cancer	0.000367	0.00062	CcSEcCtD
Lurasidone—Dizziness—Sunitinib—kidney cancer	0.000364	0.000616	CcSEcCtD
Lurasidone—Shock—Paclitaxel—kidney cancer	0.000364	0.000616	CcSEcCtD
Lurasidone—Vomiting—Sorafenib—kidney cancer	0.000364	0.000615	CcSEcCtD
Lurasidone—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000364	0.000615	CcSEcCtD
Lurasidone—Abdominal pain upper—Doxorubicin—kidney cancer	0.000364	0.000615	CcSEcCtD
Lurasidone—Nervous system disorder—Paclitaxel—kidney cancer	0.000363	0.000614	CcSEcCtD
Lurasidone—Tachycardia—Paclitaxel—kidney cancer	0.000361	0.000611	CcSEcCtD
Lurasidone—Rash—Sorafenib—kidney cancer	0.000361	0.00061	CcSEcCtD
Lurasidone—Dermatitis—Sorafenib—kidney cancer	0.000361	0.00061	CcSEcCtD
Lurasidone—Back pain—Capecitabine—kidney cancer	0.00036	0.000609	CcSEcCtD
Lurasidone—Breast disorder—Doxorubicin—kidney cancer	0.00036	0.000609	CcSEcCtD
Lurasidone—Skin disorder—Paclitaxel—kidney cancer	0.000359	0.000608	CcSEcCtD
Lurasidone—Muscle spasms—Capecitabine—kidney cancer	0.000358	0.000605	CcSEcCtD
Lurasidone—Hyperhidrosis—Paclitaxel—kidney cancer	0.000358	0.000605	CcSEcCtD
Lurasidone—Diarrhoea—Dactinomycin—kidney cancer	0.000357	0.000603	CcSEcCtD
Lurasidone—Nasopharyngitis—Doxorubicin—kidney cancer	0.000356	0.000602	CcSEcCtD
Lurasidone—ADRA2A—cortex of kidney—kidney cancer	0.000353	0.0378	CbGeAlD
Lurasidone—Gastritis—Doxorubicin—kidney cancer	0.000352	0.000596	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000351	0.000594	CcSEcCtD
Lurasidone—Vision blurred—Capecitabine—kidney cancer	0.000351	0.000593	CcSEcCtD
Lurasidone—Vomiting—Sunitinib—kidney cancer	0.00035	0.000592	CcSEcCtD
Lurasidone—Tremor—Capecitabine—kidney cancer	0.000349	0.000589	CcSEcCtD
Lurasidone—Rash—Sunitinib—kidney cancer	0.000347	0.000587	CcSEcCtD
Lurasidone—Dermatitis—Sunitinib—kidney cancer	0.000347	0.000587	CcSEcCtD
Lurasidone—Hypotension—Paclitaxel—kidney cancer	0.000346	0.000585	CcSEcCtD
Lurasidone—Dysphagia—Doxorubicin—kidney cancer	0.000344	0.000582	CcSEcCtD
Lurasidone—Influenza—Doxorubicin—kidney cancer	0.000344	0.000582	CcSEcCtD
Lurasidone—Anaemia—Capecitabine—kidney cancer	0.000344	0.000582	CcSEcCtD
Lurasidone—Eosinophilia—Doxorubicin—kidney cancer	0.000341	0.000576	CcSEcCtD
Lurasidone—Nausea—Sorafenib—kidney cancer	0.00034	0.000575	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000337	0.00057	CcSEcCtD
Lurasidone—ADRA2A—gonad—kidney cancer	0.000336	0.036	CbGeAlD
Lurasidone—ADRA2A—cardiac atrium—kidney cancer	0.000336	0.036	CbGeAlD
Lurasidone—Malaise—Capecitabine—kidney cancer	0.000336	0.000567	CcSEcCtD
Lurasidone—Angina pectoris—Doxorubicin—kidney cancer	0.000335	0.000567	CcSEcCtD
Lurasidone—Insomnia—Paclitaxel—kidney cancer	0.000335	0.000566	CcSEcCtD
Lurasidone—Vertigo—Capecitabine—kidney cancer	0.000334	0.000565	CcSEcCtD
Lurasidone—Asthenia—Vincristine—kidney cancer	0.000334	0.000565	CcSEcCtD
Lurasidone—Syncope—Capecitabine—kidney cancer	0.000334	0.000564	CcSEcCtD
Lurasidone—Leukopenia—Capecitabine—kidney cancer	0.000333	0.000563	CcSEcCtD
Lurasidone—Vomiting—Dactinomycin—kidney cancer	0.000332	0.000561	CcSEcCtD
Lurasidone—Dyspnoea—Paclitaxel—kidney cancer	0.00033	0.000558	CcSEcCtD
Lurasidone—Somnolence—Paclitaxel—kidney cancer	0.000329	0.000556	CcSEcCtD
Lurasidone—Rash—Dactinomycin—kidney cancer	0.000329	0.000556	CcSEcCtD
Lurasidone—Nausea—Sunitinib—kidney cancer	0.000327	0.000553	CcSEcCtD
Lurasidone—Loss of consciousness—Capecitabine—kidney cancer	0.000327	0.000553	CcSEcCtD
Lurasidone—Dyspepsia—Paclitaxel—kidney cancer	0.000326	0.000551	CcSEcCtD
Lurasidone—Dysuria—Doxorubicin—kidney cancer	0.000322	0.000544	CcSEcCtD
Lurasidone—Neutropenia—Doxorubicin—kidney cancer	0.000322	0.000544	CcSEcCtD
Lurasidone—Decreased appetite—Paclitaxel—kidney cancer	0.000322	0.000544	CcSEcCtD
Lurasidone—Hypertension—Capecitabine—kidney cancer	0.000321	0.000543	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000319	0.00054	CcSEcCtD
Lurasidone—Fatigue—Paclitaxel—kidney cancer	0.000319	0.000539	CcSEcCtD
Lurasidone—HTR2A—renal system—kidney cancer	0.000319	0.0342	CbGeAlD
Lurasidone—Diarrhoea—Vincristine—kidney cancer	0.000319	0.000539	CcSEcCtD
Lurasidone—Asthenia—Gemcitabine—kidney cancer	0.000317	0.000536	CcSEcCtD
Lurasidone—Myalgia—Capecitabine—kidney cancer	0.000317	0.000536	CcSEcCtD
Lurasidone—Anxiety—Capecitabine—kidney cancer	0.000316	0.000534	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000315	0.000532	CcSEcCtD
Lurasidone—Weight increased—Doxorubicin—kidney cancer	0.000313	0.00053	CcSEcCtD
Lurasidone—Pruritus—Gemcitabine—kidney cancer	0.000313	0.000529	CcSEcCtD
Lurasidone—Hyperglycaemia—Doxorubicin—kidney cancer	0.00031	0.000525	CcSEcCtD
Lurasidone—Dry mouth—Capecitabine—kidney cancer	0.00031	0.000524	CcSEcCtD
Lurasidone—Nausea—Dactinomycin—kidney cancer	0.00031	0.000524	CcSEcCtD
Lurasidone—HTR2A—kidney—kidney cancer	0.000308	0.033	CbGeAlD
Lurasidone—Dizziness—Vincristine—kidney cancer	0.000308	0.000521	CcSEcCtD
Lurasidone—Infestation NOS—Doxorubicin—kidney cancer	0.000307	0.000519	CcSEcCtD
Lurasidone—Infestation—Doxorubicin—kidney cancer	0.000307	0.000519	CcSEcCtD
Lurasidone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000303	0.000512	CcSEcCtD
Lurasidone—Diarrhoea—Gemcitabine—kidney cancer	0.000302	0.000511	CcSEcCtD
Lurasidone—Renal failure—Doxorubicin—kidney cancer	0.000302	0.00051	CcSEcCtD
Lurasidone—Infection—Capecitabine—kidney cancer	0.000302	0.00051	CcSEcCtD
Lurasidone—Shock—Capecitabine—kidney cancer	0.000299	0.000505	CcSEcCtD
Lurasidone—Urinary tract infection—Doxorubicin—kidney cancer	0.000298	0.000504	CcSEcCtD
Lurasidone—Nervous system disorder—Capecitabine—kidney cancer	0.000298	0.000504	CcSEcCtD
Lurasidone—Tachycardia—Capecitabine—kidney cancer	0.000296	0.000501	CcSEcCtD
Lurasidone—Vomiting—Vincristine—kidney cancer	0.000296	0.000501	CcSEcCtD
Lurasidone—CYP3A4—renal system—kidney cancer	0.000295	0.0316	CbGeAlD
Lurasidone—Skin disorder—Capecitabine—kidney cancer	0.000295	0.000499	CcSEcCtD
Lurasidone—Rash—Vincristine—kidney cancer	0.000294	0.000497	CcSEcCtD
Lurasidone—Hyperhidrosis—Capecitabine—kidney cancer	0.000294	0.000496	CcSEcCtD
Lurasidone—Dermatitis—Vincristine—kidney cancer	0.000293	0.000496	CcSEcCtD
Lurasidone—Abdominal pain—Paclitaxel—kidney cancer	0.000293	0.000495	CcSEcCtD
Lurasidone—Hepatobiliary disease—Doxorubicin—kidney cancer	0.00029	0.000491	CcSEcCtD
Lurasidone—Agranulocytosis—Doxorubicin—kidney cancer	0.000286	0.000484	CcSEcCtD
Lurasidone—HTR2A—gonad—kidney cancer	0.000286	0.0306	CbGeAlD
Lurasidone—CYP3A4—kidney—kidney cancer	0.000285	0.0306	CbGeAlD
Lurasidone—Hypotension—Capecitabine—kidney cancer	0.000284	0.00048	CcSEcCtD
Lurasidone—Vomiting—Gemcitabine—kidney cancer	0.000281	0.000475	CcSEcCtD
Lurasidone—Bradycardia—Doxorubicin—kidney cancer	0.00028	0.000474	CcSEcCtD
Lurasidone—Rash—Gemcitabine—kidney cancer	0.000279	0.000471	CcSEcCtD
Lurasidone—Dermatitis—Gemcitabine—kidney cancer	0.000278	0.000471	CcSEcCtD
Lurasidone—Nausea—Vincristine—kidney cancer	0.000277	0.000468	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000277	0.000468	CcSEcCtD
Lurasidone—Insomnia—Capecitabine—kidney cancer	0.000275	0.000464	CcSEcCtD
Lurasidone—Urinary tract disorder—Doxorubicin—kidney cancer	0.000272	0.00046	CcSEcCtD
Lurasidone—Connective tissue disorder—Doxorubicin—kidney cancer	0.000271	0.000458	CcSEcCtD
Lurasidone—Dyspnoea—Capecitabine—kidney cancer	0.000271	0.000458	CcSEcCtD
Lurasidone—Urethral disorder—Doxorubicin—kidney cancer	0.00027	0.000457	CcSEcCtD
Lurasidone—Dyspepsia—Capecitabine—kidney cancer	0.000267	0.000452	CcSEcCtD
Lurasidone—Asthenia—Paclitaxel—kidney cancer	0.000265	0.000449	CcSEcCtD
Lurasidone—Decreased appetite—Capecitabine—kidney cancer	0.000264	0.000446	CcSEcCtD
Lurasidone—Nausea—Gemcitabine—kidney cancer	0.000263	0.000444	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000262	0.000443	CcSEcCtD
Lurasidone—Fatigue—Capecitabine—kidney cancer	0.000262	0.000443	CcSEcCtD
Lurasidone—Pruritus—Paclitaxel—kidney cancer	0.000262	0.000443	CcSEcCtD
Lurasidone—Eye disorder—Doxorubicin—kidney cancer	0.000257	0.000435	CcSEcCtD
Lurasidone—Cardiac disorder—Doxorubicin—kidney cancer	0.000256	0.000432	CcSEcCtD
Lurasidone—Diarrhoea—Paclitaxel—kidney cancer	0.000253	0.000428	CcSEcCtD
Lurasidone—Angiopathy—Doxorubicin—kidney cancer	0.00025	0.000423	CcSEcCtD
Lurasidone—Gastrointestinal pain—Capecitabine—kidney cancer	0.000248	0.00042	CcSEcCtD
Lurasidone—Arrhythmia—Doxorubicin—kidney cancer	0.000246	0.000416	CcSEcCtD
Lurasidone—Dizziness—Paclitaxel—kidney cancer	0.000245	0.000414	CcSEcCtD
Lurasidone—Mental disorder—Doxorubicin—kidney cancer	0.000241	0.000408	CcSEcCtD
Lurasidone—Abdominal pain—Capecitabine—kidney cancer	0.00024	0.000406	CcSEcCtD
Lurasidone—Malnutrition—Doxorubicin—kidney cancer	0.00024	0.000406	CcSEcCtD
Lurasidone—Flatulence—Doxorubicin—kidney cancer	0.000236	0.0004	CcSEcCtD
Lurasidone—Vomiting—Paclitaxel—kidney cancer	0.000235	0.000398	CcSEcCtD
Lurasidone—Rash—Paclitaxel—kidney cancer	0.000233	0.000395	CcSEcCtD
Lurasidone—Dermatitis—Paclitaxel—kidney cancer	0.000233	0.000394	CcSEcCtD
Lurasidone—Back pain—Doxorubicin—kidney cancer	0.000232	0.000392	CcSEcCtD
Lurasidone—Muscle spasms—Doxorubicin—kidney cancer	0.000231	0.00039	CcSEcCtD
Lurasidone—Vision blurred—Doxorubicin—kidney cancer	0.000226	0.000382	CcSEcCtD
Lurasidone—Anaemia—Doxorubicin—kidney cancer	0.000222	0.000375	CcSEcCtD
Lurasidone—Agitation—Doxorubicin—kidney cancer	0.00022	0.000373	CcSEcCtD
Lurasidone—Nausea—Paclitaxel—kidney cancer	0.00022	0.000372	CcSEcCtD
Lurasidone—Asthenia—Capecitabine—kidney cancer	0.000218	0.000368	CcSEcCtD
Lurasidone—Malaise—Doxorubicin—kidney cancer	0.000216	0.000366	CcSEcCtD
Lurasidone—Vertigo—Doxorubicin—kidney cancer	0.000215	0.000364	CcSEcCtD
Lurasidone—Syncope—Doxorubicin—kidney cancer	0.000215	0.000364	CcSEcCtD
Lurasidone—Pruritus—Capecitabine—kidney cancer	0.000215	0.000363	CcSEcCtD
Lurasidone—Leukopenia—Doxorubicin—kidney cancer	0.000215	0.000363	CcSEcCtD
Lurasidone—Loss of consciousness—Doxorubicin—kidney cancer	0.000211	0.000356	CcSEcCtD
Lurasidone—Convulsion—Doxorubicin—kidney cancer	0.000208	0.000351	CcSEcCtD
Lurasidone—Diarrhoea—Capecitabine—kidney cancer	0.000208	0.000351	CcSEcCtD
Lurasidone—Hypertension—Doxorubicin—kidney cancer	0.000207	0.00035	CcSEcCtD
Lurasidone—Myalgia—Doxorubicin—kidney cancer	0.000204	0.000345	CcSEcCtD
Lurasidone—Anxiety—Doxorubicin—kidney cancer	0.000203	0.000344	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000203	0.000343	CcSEcCtD
Lurasidone—Dizziness—Capecitabine—kidney cancer	0.000201	0.00034	CcSEcCtD
Lurasidone—Dry mouth—Doxorubicin—kidney cancer	0.0002	0.000338	CcSEcCtD
Lurasidone—Infection—Doxorubicin—kidney cancer	0.000194	0.000329	CcSEcCtD
Lurasidone—Vomiting—Capecitabine—kidney cancer	0.000193	0.000327	CcSEcCtD
Lurasidone—Shock—Doxorubicin—kidney cancer	0.000193	0.000326	CcSEcCtD
Lurasidone—Nervous system disorder—Doxorubicin—kidney cancer	0.000192	0.000325	CcSEcCtD
Lurasidone—Rash—Capecitabine—kidney cancer	0.000191	0.000324	CcSEcCtD
Lurasidone—Dermatitis—Capecitabine—kidney cancer	0.000191	0.000323	CcSEcCtD
Lurasidone—Tachycardia—Doxorubicin—kidney cancer	0.000191	0.000323	CcSEcCtD
Lurasidone—Skin disorder—Doxorubicin—kidney cancer	0.00019	0.000322	CcSEcCtD
Lurasidone—Hyperhidrosis—Doxorubicin—kidney cancer	0.000189	0.00032	CcSEcCtD
Lurasidone—Hypotension—Doxorubicin—kidney cancer	0.000183	0.000309	CcSEcCtD
Lurasidone—Nausea—Capecitabine—kidney cancer	0.00018	0.000305	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000178	0.000302	CcSEcCtD
Lurasidone—Insomnia—Doxorubicin—kidney cancer	0.000177	0.000299	CcSEcCtD
Lurasidone—Dyspnoea—Doxorubicin—kidney cancer	0.000175	0.000295	CcSEcCtD
Lurasidone—Somnolence—Doxorubicin—kidney cancer	0.000174	0.000294	CcSEcCtD
Lurasidone—Dyspepsia—Doxorubicin—kidney cancer	0.000172	0.000291	CcSEcCtD
Lurasidone—Decreased appetite—Doxorubicin—kidney cancer	0.00017	0.000288	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000169	0.000286	CcSEcCtD
Lurasidone—Fatigue—Doxorubicin—kidney cancer	0.000169	0.000285	CcSEcCtD
Lurasidone—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00016	0.000271	CcSEcCtD
Lurasidone—Abdominal pain—Doxorubicin—kidney cancer	0.000155	0.000262	CcSEcCtD
Lurasidone—Asthenia—Doxorubicin—kidney cancer	0.00014	0.000237	CcSEcCtD
Lurasidone—Pruritus—Doxorubicin—kidney cancer	0.000138	0.000234	CcSEcCtD
Lurasidone—Diarrhoea—Doxorubicin—kidney cancer	0.000134	0.000226	CcSEcCtD
Lurasidone—Dizziness—Doxorubicin—kidney cancer	0.000129	0.000219	CcSEcCtD
Lurasidone—Vomiting—Doxorubicin—kidney cancer	0.000124	0.00021	CcSEcCtD
Lurasidone—Rash—Doxorubicin—kidney cancer	0.000123	0.000209	CcSEcCtD
Lurasidone—Dermatitis—Doxorubicin—kidney cancer	0.000123	0.000209	CcSEcCtD
Lurasidone—Nausea—Doxorubicin—kidney cancer	0.000116	0.000197	CcSEcCtD
